Aegis Capital Corp. acted as Exclusive Placement Agent on a Registered Direct Offering and Concurrent Private Placement of ~$2,900,000 for Dyadic International, Inc. (Nasdaq:DYAI)
- Aug 18
- 1 min read
8/14/2026 - Aegis Capital Corp. acted as Exclusive Placement Agent on a Registered Direct Offering and Concurrent Private Placement of ~$2,900,000 for Dyadic International, Inc. (Nasdaq:DYAI)
About Dyadic International, Inc.
Dyadic Applied BioSolutions is a global biotechnology company that aims to develop and commercialize scalable, non-animal protein production platforms to meet growing global demand across the life sciences, food and nutrition, and bio-industrial markets. These high-value proteins are designed to enable customers to develop more efficient, scalable and sustainable products. Dyadic's proprietary Dapibus™ and C1 expression systems support rapid, cost-effective and flexible manufacturing.
About Aegis Capital Corp.
Aegis Capital Corporation ("Aegis") has been in the wealth management and investment banking business since 1984. Aegis is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Aegis also provides research and sales and trading services to institutional investors. Aegis offers its investment representatives a conflict free service platform and is able to provide a full-range of products and services including investment banking, wealth management, insurance, retirement planning, structured products, private equity, alternatives, equity research, fixed income and special purpose vehicles.
It's impressive to see Dyadic International securing nearly $3 million through this offering, which clearly shows investor confidence in their future projects. I’m curious how this funding might accelerate their development of AI-driven tools that could benefit students academically. ai gpa calculator
The combination of a registered direct offering and concurrent private placement gave Dyadic International a reported $2.9 million financing supported by Aegis Capital. The company’s focus on scalable, non-animal protein production connects the fundraising to applications across life sciences, food and nutrition, and bio-industrial markets. video to prompt
It’s interesting to see how Dyadic International is leveraging strategic financing to support their ongoing projects. Knowing the exact end-of-life dates and missed CVEs really helps developers plan timely upgrades without compromising security. EOL tracker
It’s interesting to see Dyadic International securing nearly $3 million through this offering—it shows strong investor confidence in their future projects. I’m curious how this influx of capital might impact their next steps in product innovation or market expansion. online harmonium
This was an interesting read with some great information. Anyone looking for a creative way to discover unusual animals might enjoy a random creature generator. It can provide unexpected ideas and make learning about different creatures more enjoyable, especially for students, writers, artists, or curious readers.